PPAR␣ has emerged as a key regulator of cell growth and survival, whose activity is modulated by a number of synthetic and natural ligands. Here we shall review the activities of PPAR␣ ligands in the control of immune cell prolifera- tion, differentiation and apoptosis and their potential therapeutic applications to hematological malignancies.

Ulivieri, C., Baldari, C. (2007). The potential of peroxisome proliferator-activated receptor gamma (PPARgamma) ligands in the treatment of hematological malignancies. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 7, 877-887.

The potential of peroxisome proliferator-activated receptor gamma (PPARgamma) ligands in the treatment of hematological malignancies

ULIVIERI, CRISTINA;BALDARI, COSIMA
2007-01-01

Abstract

PPAR␣ has emerged as a key regulator of cell growth and survival, whose activity is modulated by a number of synthetic and natural ligands. Here we shall review the activities of PPAR␣ ligands in the control of immune cell prolifera- tion, differentiation and apoptosis and their potential therapeutic applications to hematological malignancies.
2007
Ulivieri, C., Baldari, C. (2007). The potential of peroxisome proliferator-activated receptor gamma (PPARgamma) ligands in the treatment of hematological malignancies. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 7, 877-887.
File in questo prodotto:
File Dimensione Formato  
Ulivieri and Baldari Mini-Rev med chem. 2007.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 289.76 kB
Formato Adobe PDF
289.76 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/21825
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo